SCHEMBL21628608

SCHEMBL21628608

COC(=O)c1ccc(Oc2ccc(C3CC3)cc2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.45
SCN8A Q9UQD0 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.43
OPRK1 P41145 9/20 0.43
OPRM1 P35372 8/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
OPRD1 P41143 6/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
MET P08581 1/20 0.41
AXL P30530 1/20 0.41
PARP10 Q53GL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628801 0.95 ALDH1A1 (0.46) USP2SCN8ASCN10AOPRK1OPRM1
SCHEMBL21628413 0.95 OPRK1 (0.44) USP2SCN8ASCN10AOPRK1OPRM1
SCHEMBL21628766 0.94 ALDH1A1 (0.47) USP2OPRK1OPRM1ALDH1A1HPGD
SCHEMBL21628529 0.94 ALDH1A1 (0.47) USP2OPRK1OPRM1ALDH1A1HPGD
SCHEMBL21628635 0.86 OPRK1 (0.45) OPRK1OPRM1ALDH1A1NPSR1OPRD1
SCHEMBL21628718 0.86 HPGD (0.48) SCN8ASCN10AOPRK1OPRM1HPGD
SCHEMBL21628536 0.85 LMNA (0.51) SCN8ASCN10AOPRK1OPRM1OPRD1
SCHEMBL21628599 0.85 OPRK1 (0.54) SCN8ASCN10AOPRK1OPRM1OPRD1
SCHEMBL21628819 0.84 PARP10 (0.54) SCN8ASCN10AOPRK1OPRM1ALDH1A1
SCHEMBL21628619 0.84 ALDH1A1 (0.48) SCN8ASCN10AOPRK1OPRM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK USP2 2436/4885SCN8A 4600/4885SCN10A 4163/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK USP2 2436/4885SCN8A 4600/4885SCN10A 4163/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK USP2 2531/4885SCN8A 4660/4885SCN10A 4351/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK USP2 2436/4885SCN8A 4600/4885SCN10A 4163/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR USP2 2314/4885SCN8A 2782/4885SCN10A 2496/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK USP2 2436/4885SCN8A 4600/4885SCN10A 4163/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK USP2 2436/4885SCN8A 4600/4885SCN10A 4163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.